Greenwich LifeSciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Poseida Therapeutics (PSTX), Greenwich LifeSciences (GLSI) and ACELYRIN, INC. (SLRN)
HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $36 Price Target
Expanding Horizons: Bullish Buy Rating as Greenwich LifeSciences's Breast Cancer Trial Goes Pan-European
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Lowers Price Target to $36
Greenwich LifeSciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), BioMarin Pharmaceutical (BMRN) and Greenwich LifeSciences (GLSI)
HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Lowers Price Target to $38
H.C. Wainwright Sticks to Its Buy Rating for Greenwich LifeSciences (GLSI)
Analysts Conflicted on These Healthcare Names: Nabriva (NBRV), Vir Biotechnology (VIR) and Greenwich LifeSciences (GLSI)
Analysts Offer Insights on Healthcare Companies: Evofem Biosciences (OtherEVFM), Greenwich LifeSciences (GLSI) and Chinook Therapeutics (KDNY)
No Data